We’d like to share some information for patients related to navigating Medicare benefits, courtesy of Caring.com.
Amidst the COVID-19 (Coronavirus) outbreak in the U.S. and across the world, we wanted to communicate information about precautions we are taking at AIROS Medical and provide an update about our business operations.
We will proudly present our device line at Medtrade Spring 2020 in Las Vegas next week. Medtrade is a conference that brings together Durable Medical Equipment/Home Medical Equipment companies, rehabilitation therapists, home health agencies and nurses, hospitals, and various other healthcare providers.
We are proud to announce that AIROS will again sponsor the annual “Run/Walk to Fight Lymphedema & Lymphatic Diseases,” presented by the Lymphatic Education & Research Network (LE&RN). Actor Kathy Bates is the national spokesperson for LE&RN.
AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy devices that treat cancer-related lymphedema as well as venous disorders, today announced it has received trademark registration from the United States Patent and Trademark Office (USPTO) for its company and brand name, “AIROS”.
AIROS Medical traveled extensively on the trade show and conference circuit in 2019, generating both brand awareness and clinical interest in compression-related therapy options. Here is a look at some of the medical professionals, clinicians, and patients we had the honor of connecting with last year.
Audubon, PA – January 13, 2020 – AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy devices that treat cancer-related lymphedema and venous complications, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its updated AIROS 8 Sequential Compression Therapy device and garment system.
AIROS Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy, today announced it will present its line of compression therapy devices and garments at the 9th International Lymphedema Framework (ILF) Conference.